David Mulham's most recent trade in Usana Health Sciences Inc was a trade of 3,234 Common Stock done at an average price of $33.0 . Disclosure was reported to the exchange on March 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 10 Mar 2025 | 3,234 | 12,775 (0%) | 0% | 33.0 | 106,670 | Common Stock |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 18,641 | 32,671 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 2,573 | 16,009 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 2,573 | 14,030 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,677 | 16,603 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,677 | 13,436 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,377 | 19,837 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,377 | 10,202 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,557 | 11,759 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,557 | 18,280 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Sale of securities on an exchange or to another person at price $ 47.76 per share. | 29 Feb 2024 | 4,311 | 7,825 (0%) | 0% | 47.8 | 205,872 | Common Stock |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 10,293 | 22,214 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,676 | 12,136 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,676 | 11,921 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,377 | 8,904 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,377 | 15,153 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,556 | 10,460 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,556 | 13,597 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 1,079 | 6,527 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 1,079 | 17,530 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Sale of securities on an exchange or to another person at price $ 65.34 per share. | 15 Aug 2023 | 2,159 | 5,448 (0%) | 0% | 65.3 | 141,067 | Common Stock |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Sale of securities on an exchange or to another person at price $ 66.28 per share. | 11 Aug 2023 | 1,080 | 7,607 (0%) | 0% | 66.3 | 71,585 | Common Stock |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 31 Jul 2023 | 3,354 | 8,687 (0%) | 0% | 65 | 218,010 | Common Stock |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 15 Jun 2023 | 1,557 | 12,041 (0%) | 0% | 61 | 94,977 | Common Stock |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Sale of securities on an exchange or to another person at price $ 67.40 per share. | 28 Apr 2023 | 1,138 | 13,598 (0%) | 0% | 67.4 | 76,699 | Common Stock |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 9,508 | 21,843 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,677 | 14,736 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,677 | 18,609 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,557 | 20,286 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,557 | 13,059 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,138 | 12,335 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,138 | 11,502 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,080 | 10,364 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,080 | 13,473 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 6,226 | 16,230 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,677 | 14,553 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,677 | 9,374 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,399 | 10,004 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,399 | 7,697 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,138 | 11,403 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,138 | 6,298 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,079 | 5,160 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,079 | 12,541 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 101.50 per share. | 07 Dec 2021 | 873 | 4,081 (0%) | 0% | 101.5 | 88,610 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 102.00 per share. | 15 Nov 2021 | 569 | 4,954 (0%) | 0% | 102 | 58,038 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 100.74 per share. | 11 Nov 2021 | 1,111 | 5,523 (0%) | 0% | 100.7 | 111,922 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 101.77 per share. | 04 Nov 2021 | 1,398 | 6,634 (0%) | 0% | 101.8 | 142,274 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 99.64 per share. | 03 Nov 2021 | 1,277 | 8,032 (0%) | 0% | 99.6 | 127,234 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 639 | 9,309 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 639 | 13,620 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 97.53 per share. | 26 Feb 2021 | 2,144 | 9,309 (0%) | 0% | 97.5 | 209,106 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 99.00 per share. | 26 Feb 2021 | 639 | 8,670 (0%) | 0% | 99 | 63,261 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Sale of securities on an exchange or to another person at price $ 91.00 per share. | 18 Feb 2021 | 3,145 | 11,453 (0%) | 0% | 91 | 286,195 | Common Stock |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2021 | 6,707 | 14,259 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 873 | 7,552 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 873 | 14,508 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,398 | 8,425 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,398 | 13,635 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,138 | 10,365 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,138 | 11,695 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,080 | 10,557 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,080 | 11,503 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 542 | 12,237 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 542 | 9,823 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 638 | 8,877 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 638 | 12,583 | - | - | Restricted Stock Units |